关于成人2型糖尿病/糖尿病前期治疗的伊拉克专家共识

2020-08-05 Clin Med Insights Endocrinol Diabetes . 2020 Aug 19;13:1179551420942232

伊拉克公共部门和私营部门之间的2型糖尿病（T2DM）管理差异很大。这种差异是由于治疗途径差异。达成共识的目的是针对伊拉克的当地障碍，首次就如何管理T2DM患者提出统一建议。这些共识得到了来自伊拉

中文标题：

英文标题：

Iraqi Experts Consensus on the Management of Type 2 Diabetes/Prediabetes in Adults

发布机构：

发布日期：

2020-08-05

简要介绍：

伊拉克公共部门和私营部门之间的2型糖尿病（T2DM）管理差异很大。这种差异是由于治疗途径差异。达成共识的目的是针对伊拉克的当地障碍，首次就如何管理T2DM患者提出统一建议。这些共识得到了来自伊拉克各地的伊拉克专家和糖尿病专家小组的认可。在整个建议中使用了最新的证据水平。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=f0aaa1c0019655b4, title=关于成人2型糖尿病/糖尿病前期治疗的伊拉克专家共识, enTitle=Iraqi Experts Consensus on the Management of Type 2 Diabetes/Prediabetes in Adults, guiderFrom=Clin Med Insights Endocrinol Diabetes . 2020 Aug 19;13:1179551420942232, authorId=0, author=, summary=伊拉克公共部门和私营部门之间的2型糖尿病（T2DM）管理差异很大。这种差异是由于治疗途径差异。达成共识的目的是针对伊拉克的当地障碍，首次就如何管理T2DM患者提出统一建议。这些共识得到了来自伊拉, cover=, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Wed Aug 05 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p>伊拉克公共部门和私营部门之间的2型糖尿病（T2DM）管理差异很大。这种差异是由于治疗途径差异。达成共识的目的是针对伊拉克的当地障碍，首次就如何管理T2DM患者提出统一建议。这些共识得到了来自伊拉克各地的伊拉克专家和糖尿病专家小组的认可。在整个建议中使用了最新的证据水平。</p>, tagList=[TagDto(tagId=216, tagName=糖尿病)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3235, appHits=280, showAppHits=0, pcHits=350, showPcHits=2955, likes=0, shares=11, comments=9, approvalStatus=1, publishedTime=Mon Sep 07 16:23:17 CST 2020, publishedTimeString=2020-08-05, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=fbzhang, createdTime=Mon Sep 07 16:22:59 CST 2020, updatedBy=4754896, updatedName=fbzhang, updatedTime=Sat Jan 06 03:44:59 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=66.pdf)])

66.pdf

下载请点击：

评论区 (7)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=999238, encodeId=2a31999238da, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJTDMBicFvucwUAzOF6GI0WuyHCmdmZic6mcNOUMYJnlcpgNAvJH9teibricvt2rPupLesr2fv0Arjo7w/132, createdBy=a4f62251450, createdName=ms2320155838802602, createdTime=Tue Jul 13 22:55:30 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970649, encodeId=94889e0649da, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210328/d1c2a77350ef4b7b8dd3973786c5553f/8505b172b90c4ec7898e5052a1252dad.jpg, createdBy=7a085451034, createdName=hssm, createdTime=Thu Jun 03 18:18:55 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950972, encodeId=98ce9509e202, content=刚想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c812123899, createdName=03463, createdTime=Thu Mar 25 12:10:56 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950599, encodeId=d109950599ff, content=很好，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95ce4810113, createdName=1475098666, createdTime=Wed Mar 24 06:26:06 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920151, encodeId=3fc592015164, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01f52568974, createdName=1257c336m18暂无昵称, createdTime=Tue Jan 26 22:57:08 CST 2021, time=2021-01-26, status=1, ipAttribution=)]
2021-07-13 ms2320155838802602

学习

56 0
[GetPortalCommentsPageByObjectIdResponse(id=999238, encodeId=2a31999238da, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJTDMBicFvucwUAzOF6GI0WuyHCmdmZic6mcNOUMYJnlcpgNAvJH9teibricvt2rPupLesr2fv0Arjo7w/132, createdBy=a4f62251450, createdName=ms2320155838802602, createdTime=Tue Jul 13 22:55:30 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970649, encodeId=94889e0649da, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210328/d1c2a77350ef4b7b8dd3973786c5553f/8505b172b90c4ec7898e5052a1252dad.jpg, createdBy=7a085451034, createdName=hssm, createdTime=Thu Jun 03 18:18:55 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950972, encodeId=98ce9509e202, content=刚想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c812123899, createdName=03463, createdTime=Thu Mar 25 12:10:56 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950599, encodeId=d109950599ff, content=很好，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95ce4810113, createdName=1475098666, createdTime=Wed Mar 24 06:26:06 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920151, encodeId=3fc592015164, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01f52568974, createdName=1257c336m18暂无昵称, createdTime=Tue Jan 26 22:57:08 CST 2021, time=2021-01-26, status=1, ipAttribution=)]
2021-06-03 hssm

学习

63 0
[GetPortalCommentsPageByObjectIdResponse(id=999238, encodeId=2a31999238da, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJTDMBicFvucwUAzOF6GI0WuyHCmdmZic6mcNOUMYJnlcpgNAvJH9teibricvt2rPupLesr2fv0Arjo7w/132, createdBy=a4f62251450, createdName=ms2320155838802602, createdTime=Tue Jul 13 22:55:30 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970649, encodeId=94889e0649da, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210328/d1c2a77350ef4b7b8dd3973786c5553f/8505b172b90c4ec7898e5052a1252dad.jpg, createdBy=7a085451034, createdName=hssm, createdTime=Thu Jun 03 18:18:55 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950972, encodeId=98ce9509e202, content=刚想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c812123899, createdName=03463, createdTime=Thu Mar 25 12:10:56 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950599, encodeId=d109950599ff, content=很好，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95ce4810113, createdName=1475098666, createdTime=Wed Mar 24 06:26:06 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920151, encodeId=3fc592015164, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01f52568974, createdName=1257c336m18暂无昵称, createdTime=Tue Jan 26 22:57:08 CST 2021, time=2021-01-26, status=1, ipAttribution=)]
2021-03-25 03463

刚想学习

62 0
[GetPortalCommentsPageByObjectIdResponse(id=999238, encodeId=2a31999238da, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJTDMBicFvucwUAzOF6GI0WuyHCmdmZic6mcNOUMYJnlcpgNAvJH9teibricvt2rPupLesr2fv0Arjo7w/132, createdBy=a4f62251450, createdName=ms2320155838802602, createdTime=Tue Jul 13 22:55:30 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970649, encodeId=94889e0649da, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210328/d1c2a77350ef4b7b8dd3973786c5553f/8505b172b90c4ec7898e5052a1252dad.jpg, createdBy=7a085451034, createdName=hssm, createdTime=Thu Jun 03 18:18:55 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950972, encodeId=98ce9509e202, content=刚想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c812123899, createdName=03463, createdTime=Thu Mar 25 12:10:56 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950599, encodeId=d109950599ff, content=很好，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95ce4810113, createdName=1475098666, createdTime=Wed Mar 24 06:26:06 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920151, encodeId=3fc592015164, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01f52568974, createdName=1257c336m18暂无昵称, createdTime=Tue Jan 26 22:57:08 CST 2021, time=2021-01-26, status=1, ipAttribution=)]
2021-03-24 1475098666

很好，学习了

70 0
[GetPortalCommentsPageByObjectIdResponse(id=999238, encodeId=2a31999238da, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJTDMBicFvucwUAzOF6GI0WuyHCmdmZic6mcNOUMYJnlcpgNAvJH9teibricvt2rPupLesr2fv0Arjo7w/132, createdBy=a4f62251450, createdName=ms2320155838802602, createdTime=Tue Jul 13 22:55:30 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970649, encodeId=94889e0649da, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210328/d1c2a77350ef4b7b8dd3973786c5553f/8505b172b90c4ec7898e5052a1252dad.jpg, createdBy=7a085451034, createdName=hssm, createdTime=Thu Jun 03 18:18:55 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950972, encodeId=98ce9509e202, content=刚想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c812123899, createdName=03463, createdTime=Thu Mar 25 12:10:56 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950599, encodeId=d109950599ff, content=很好，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95ce4810113, createdName=1475098666, createdTime=Wed Mar 24 06:26:06 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920151, encodeId=3fc592015164, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01f52568974, createdName=1257c336m18暂无昵称, createdTime=Tue Jan 26 22:57:08 CST 2021, time=2021-01-26, status=1, ipAttribution=)]
2021-01-26 1257c336m18暂无昵称

非常好

87 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

内分泌科指南

关于成人2型糖尿病/糖尿病前期治疗的伊拉克专家共识

相关指南

科室

工具

服务